July 2018 FDA Recall Drug by Medgyn Products, Inc.
D-0917-2018 - CGMP Deviations

This Class II drug recall was voluntarily initiated by Medgyn Products, Inc. on July 3, 2018 for the product Drug. The FDA reported the reason for recall as cgmp deviations. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0917-2018

Reason for Recall
CGMP Deviations: The manufacturer of this product recalled because they were not manufactured under current good manufacturing practices.
Initiated
07-03-2018
Reported
07-18-2018
Quantity
2750 boxes

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Medgyn Products, Inc.
Nationwide in the USA, Barbados, Cayman Islands, Chile, Cyprus, Ecuador, El Salvador, Guatemala, Hong Kong, Kuwait, Lebanon, Malaysia, Maldives, Mexico, Mongolia, Montenegro, Mozambique, Pakistan, Paraguay, Peru, Republic of Georgia, Serbia, South Africa, Tanzania, United Arab Emirates, Venezuela, and Vietnam.
Monsel's Solution (Ferric Subsulfate), 20%, packaged as 12 single application vials and 12 applicators, 8 mL per box, Manufactured For: MedGyn Products, Inc., 100 W. Industrial Rd., Addison, IL 60101 USA; Manufactured By: BioDiagnostics Intl, 555 West Lambert Road Unit-C, Brea, CA 92821, NDC 42721-112-08.

Batch or Lot Expiration Information

Lot# s: all lots within expiry